Not applicableUnknownNCT05161728What this trial is testingPSMA Response in Metastasized Hormone Sensitive Prostate CancerWho this might be right forProstate Cancer Roderick van den Bergh 150
Testing effectiveness (Phase 2)Study completedNCT01784913What this trial is testingA Phase I/IIa Study of UV1 Vaccine in Patients With Prostate CancerWho this might be right forProstate Cancer Ultimovacs ASA 22
Not applicableStudy completedNCT05381311What this trial is testingSurvey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) StudyWho this might be right forProstate CancerMetastatic Hormone-sensitive Prostate Cancer Astellas Pharma Global Development, Inc. 1,020
Not applicableNot Yet RecruitingNCT07837063What this trial is testingMonitoring Treatment Response With Urine and Serum Metabolome Markers in Patients Treated With Novel Hormone Therapy and Have Either Hormone Sensitive Metastatic Prostate Cancer or Disease Progression on Treatment.Who this might be right forCancerUrology The Clatterbridge Cancer Centre NHS Foundation Trust 40
Testing effectiveness (Phase 2)Looking for participantsNCT05720130What this trial is testingPhase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).Who this might be right forProstate CancerMetastatic Castration-resistant Prostate CancerMetastatic Hormone Sensitive Prostate Cancer AdvanCell Pty Limited 100
Testing effectiveness (Phase 2)Study completedNCT03899467What this trial is testingThe Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPCWho this might be right forMetastatic Castrate Resistant Prostate Cancer (mCRPC)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Suzhou Kintor Pharmaceutical Inc, 61
Not applicableLooking for participantsNCT04612907What this trial is testingDifferent Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate CancerWho this might be right forProstate CancerRadiotherapy Side EffectMetastatic Cancer Umeå University 420
Testing effectiveness (Phase 2)Looking for participantsNCT06244004What this trial is testingFDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY TrialWho this might be right forCastration-Sensitive Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8 Northwestern University 125
Not applicableStudy completedNCT06915714What this trial is testingThe Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate CancerWho this might be right forProstate Cancer Metastatic DiseasePET / CT Sun Yat-sen University 45
Large-scale testing (Phase 3)Looking for participantsNCT07333066What this trial is testingPhase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.Who this might be right forMetastatic Hormone-sensitive Prostate Cancer Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD 320
Testing effectiveness (Phase 2)Active Not RecruitingNCT05241860What this trial is testingTesting Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)Who this might be right forCastration-Sensitive Prostate CarcinomaStage IV Prostate Cancer AJCC v8 Alliance for Clinical Trials in Oncology 79
Early research (Phase 1)Active Not RecruitingNCT06229366What this trial is testing[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate CancerWho this might be right forProstate CancerMetastatic Castration-resistant Prostate CancerOligometastatic Prostate Carcinoma+1 more Eli Lilly and Company 142
Large-scale testing (Phase 3)Active Not RecruitingNCT04076059What this trial is testingAn Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)Who this might be right forMetastatic Hormone Sensitive Prostate Cancer Astellas (Beijing) Pharmaceutical R&D Co., Ltd. 180
Large-scale testing (Phase 3)Looking for participantsNCT03903835What this trial is testingProBio: A Biomarker Driven Study in Patients With Metastatic Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Karolinska Institutet 750
Testing effectiveness (Phase 2)Active Not RecruitingNCT04262154What this trial is testingStudy of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate CancerWho this might be right forMetastatic Prostate Cancer Memorial Sloan Kettering Cancer Center 28
Large-scale testing (Phase 3)Ended earlyNCT04409288What this trial is testingPatient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate CancerWho this might be right forProstate Cancer Chinese University of Hong Kong 74
Testing effectiveness (Phase 2)Looking for participantsNCT06654336What this trial is testingStudy of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)Who this might be right forProstate AdenocarcinomaCastration Sensitive Prostate Cancer Ontario Clinical Oncology Group (OCOG) 162
Testing effectiveness (Phase 2)UnknownNCT02913859What this trial is testingHormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate CancerWho this might be right forProstate Cancer University Hospital Sestre Milosrdnice 60
Large-scale testing (Phase 3)Looking for participantsNCT06350825What this trial is testingCytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC PatientsWho this might be right forMetastatic Prostate CancerTherapy, Directly Observed The First Affiliated Hospital with Nanjing Medical University 200
Early research (Phase 1)Active Not RecruitingNCT06193993What this trial is testingEffect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer PatientsWho this might be right forProstate CancerMetastatic CancerHormone Sensitive Prostate Cancer+1 more National University Hospital, Singapore 10